96 related articles for article (PubMed ID: 14520530)
1. Evaluation of malignancy using Ki-67 labeling index for gastric stromal tumor.
Nagasako Y; Misawa K; Kohashi S; Hasegawa K; Okawa Y; Sano H; Takada A; Sato H
Gastric Cancer; 2003; 6(3):168-72. PubMed ID: 14520530
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients.
Fujimoto Y; Nakanishi Y; Yoshimura K; Shimoda T
Gastric Cancer; 2003; 6(1):39-48. PubMed ID: 12673425
[TBL] [Abstract][Full Text] [Related]
3. Risk Classification using the Ki-67 Labeling Index for Surgically-Treated Gastric Gastrointestinal Stromal Tumors.
Miki Y; Kawamura T; Sugisawa N; Makuuchi R; Nakajima T; Tokunaga M; Tanizawa Y; Bando E; Terashima M
Hepatogastroenterology; 2015 Jun; 62(140):919-23. PubMed ID: 26902028
[TBL] [Abstract][Full Text] [Related]
4. Surgery of upper GI gastrointestinal stromal tumors: our experience, prognostic analysis.
Kasetsermwiriya W; Nagai E; Nakata K; Nagayoshi Y; Shimizu S; Tanaka M
Hepatogastroenterology; 2015; 62(137):87-92. PubMed ID: 25911874
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of gastric gastrointestinal stromal tumors: analysis of 92 operated patients.
Lai IR; Chen CN; Lin MT; Lee PH
Dig Surg; 2008; 25(3):208-12. PubMed ID: 18577866
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic significance of Ki-67 expression in patients undergoing surgical resection for gastrointestinal stromal tumor].
Jeong SY; Park WW; Kim YS; Park YI; Kim SH; Yoon WJ; Moon JS; Lee BM; Hong SW; Kang YK
Korean J Gastroenterol; 2014 Aug; 64(2):87-92. PubMed ID: 25168050
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic ultrasound-guided fine-needle aspiration biopsy for the diagnosis of gastrointestinal stromal tumors in the stomach.
Okubo K; Yamao K; Nakamura T; Tajika M; Sawaki A; Hara K; Kawai H; Yamamura Y; Mochizuki Y; Koshikawa T; Inada K
J Gastroenterol; 2004 Aug; 39(8):747-53. PubMed ID: 15338368
[TBL] [Abstract][Full Text] [Related]
9. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Ki-67 and p53 expression in primary and repeated liver metastases of GISTs.
Gunji Y; Nikaidou T; Okazumi S; Matsubara H; Shimada H; Nabeya Y; Aoki T; Makino H; Miyazaki S; Ochiai T
Hepatogastroenterology; 2005; 52(63):829-32. PubMed ID: 15966214
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
[TBL] [Abstract][Full Text] [Related]
12. p27 Labeling index and proliferation in gastrointestinal stromal tumors: correlations with clinicopathologic factors and recurrence.
Gelen T; Elpek GO; Aksoy NH; Ogüş M; Keleş N
Jpn J Clin Oncol; 2003 Jul; 33(7):346-52. PubMed ID: 12949061
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of clinicopathological factors related to the prognosis of gastric neuroendocrine carcinoma.
Xie JW; Sun YQ; Feng CY; Zheng CH; Li P; Wang JB; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Yang YH; Huang CM
Eur J Surg Oncol; 2016 Oct; 42(10):1464-70. PubMed ID: 27570115
[TBL] [Abstract][Full Text] [Related]
14. P53 and MIB-1 expression in gastrointestinal stromal tumor (GIST) of the stomach.
Hata Y; Ishigami S; Natsugoe S; Nakajo A; Okumura H; Miyazono F; Matsumoto M; Hokita S; Aikou T
Hepatogastroenterology; 2006; 53(70):613-5. PubMed ID: 16995473
[TBL] [Abstract][Full Text] [Related]
15. Elevated (> or = 10%) MIB-1 proliferative index correlates with poor outcome in gastric stromal tumor patients: a study of 35 cases.
Toquet C; Le Néel JC; Guillou L; Renaudin K; Hamy A; Heymann MF; Simon-Valla S; Le Borgne J; Maugard C; Fiche M
Dig Dis Sci; 2002 Oct; 47(10):2247-53. PubMed ID: 12395897
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of gastrointestinal stromal tumors of the stomach: report of 28 cases.
Wu Y; Zhu X; Ding Y
Ann Clin Lab Sci; 2007; 37(1):15-21. PubMed ID: 17311865
[TBL] [Abstract][Full Text] [Related]
18. Serosal penetration is an important prognostic factor for gastrointestinal stromal tumors.
Vallböhmer D; Marcus HE; Baldus SE; Brabender J; Drebber U; Metzger R; Hölscher AH; Schneider PM
Oncol Rep; 2008 Oct; 20(4):779-83. PubMed ID: 18813818
[TBL] [Abstract][Full Text] [Related]
19. Expression of alpha6 integrin subunit is associated with malignancy in gastric gastrointestinal stromal tumors.
Takeyama H; Funahashi H; Sawai H; Takahashi H; Yamamotorm M; Akamo Y; Manabe T
Med Sci Monit; 2007 Feb; 13(2):CR51-6. PubMed ID: 17261983
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
